Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
Hydrogels are biocompatible drug delivery systems by which the physical properties can be controlled by the cross-linking density. Hydrogels were prepared by copolymerization of acrylic acid monomers in the presence of poly(ethylene glycol)(PEG) to form polyethylene diacrylate (PEDGA). Various molecular weights of PEGs were used for the synthesis of PEGDA to study the effect of molecular weight of PEG on the properties of hydrogels. These hydrogels were further characterized for free water, swelling..


Pharmaceutical Technology


8. N.A. Peppas et al., "Hydrogels in Pharmaceutical Formulations," Eur. J. Pharm. Biopharm. 50 (1), 27–46 (2000).

9. V.R. Patel and M.M. Amiji, "Preparation and Characterization of Freeze-Dried Chitosan Poly(ethylene oxide) Hydrogels for Site-Specific Antibiotic Delivery in the Stomach," Pharm. Res. 13 (44), 588–593 (1996).

10. V.R. Sinha and L. Khosla, "Bioabsorbable Polymers for Implantable Therapeutic Systems." Drug Dev. Ind. Pharm. 24 (12), 1129–1138 (1998).

11. J.Y. Fang et al., "Transdermal Iontophoresis of Sodium Nonivamide Acetate IV Effect of Polymer Formulations," Int. J. Pharm.173 (1–2), 127–140 (1998).

12. J.Y. Fang et al.,"Evaluation of Transdermal Iontophoresis of Enoxacin from Polymer Formulations: In Vitro Permeation and In vivo Microdialysis Using Wister Rat as an Animal Model," Int. J. Pharm. 180 (2), 137–149 (1999).

13. O.M. Conaghey, J. Currish, and O.I. Corrigan, "Iontophoretically Assisted In Vitro Membrane Transport of Nicotine from a Hydrogel Containing Ion Exchange Resins," Int. J. Pharm. 170 (2), 225–237 (1998).

14. A. Kikuchi and T. Okano, "Pulsatile Drug Release Control Using Hydrogels," Adv. Drug Del. Rev. 54 (1), 53–77 (2002).

15. T.A. Holland, Y. Tabata, and A.G. Mikos, "Dual Growth Factor Delivery from Degradable Oligo(Poly(ethylene glycol) Fumarate) Hydrogel Scaffolds for Cartilage Tissue Engineering," J. Controlled Release 101 (1–3), 111–125 (2005).

16. S.V. Vinogradov, T.K. Bronich, and A.V. Kabanov, "Nanosized Cationic Hydrogels for Drug Delivery: Preparation, Properties and Interactions with Cells," Adv. Drug Del. Rev. 54 (1), 135–147 (2002).

17. L.F. Wang, S.S. Shen, and S.C. Lu, "Synthesis and Characterization of Chondroitin Sulfate-Methacrylate Hydrogels," Carbohydrate Polymers 52 (4), 389–396 (2003).

18. G.V Mooteo, L. Vervoort, and R. Kinget, "Characterization of Methacrylated Inulin Hydrogels Designed for Colon Targeting: In Vitro Release of BSA," Pharm. Res. 20 (2), 303–307 (2003).

19. S.N. Park et al., "Biological Characterization of EDC Crosslinked Collagen-Hyaluronic Acid Matrix in Dermal Tissue Restoration," Biomaterials 24 (9), 1631–1641 (2003).

20. S. Cai et al., "Injectable Glycosaminoglycan Hydrogels for Controlled Release of Human Basic Fibroblast Growth Factor," Biomaterials 26 (30), 6054–6067 (2005).

21. X. Lou et al., "Morphological and Topographic Effects on Calcification Tendency of pHEMA Hydrogels." Biomaterials 26 (29), 5808–5817 (2005).


ADVERTISEMENT

RELATED CONTENT
Roche Recalls Viracept
Copolymerized PEGlyated Acrylate Hydrogels for Delivery of Dicolofenac Sodium
The Effect of Core and Coating Composition on Drug Release from Directly Compressed Time-Controlled Release Tablets
Near-Infrared Assay and Content Uniformity of Tablets
Maintain Your Moving Parts
blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
44%
Facility/environment problems
0%
Process development problems
11%
Production equipment downtime
11%
Raw material supply problems
11%
Regulatory restrictions
0%
Business decisions to limit production
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Patent Settlements Become More Risky
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Source: Pharmaceutical Technology,
Click here